Jill A. Metz

Jill A. Metz

Auto-generated profile, based on publicly available information

Jill A. Metz

Division of Nephrology, Hypertension, and Clinical Pharmacology, Suite 262, Oregon Health Sciences University, 3314 SW Veterans Hospital Rd, Portland, OR 97201-2940.

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2000 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
JMJill A. Metz
Jill A. Metz
JSJudith S. Stern
Judith S. Stern
PKPenny Kris-Etherton
Penny Kris-Etherton
MRMolly E. Reusser
Molly E. Reusser
CMCynthia D. Morris
Cynthia D. Morris
DMDavid A. McCarron
David A. McCarron
RATES OF obesity and overweight in the United States are at an all-time high, affecting an estimated 97 million adults, or roughly 55% of persons aged 20 years or older.1 The medical risks of excess body weight are well documented, with primary risk manifest in the morbidity and mortality associated with cardiovascular disease and type 2 diabetes mellitus. For overweight individuals with or at high risk of developing these conditions, weight reduction remains the first-line treatment strategy; even modest weight loss has been shown to decrease plasma lipid levels and high blood pressure and, in diabetic patients, to improve glycemic control.2-4 However, realization of the health benefits of weight loss requires long-term compliance with therapeutic diets, and it is well established that the difficulties inherent in dietary compliance are a major cause of the failure of most weight reduction efforts.

1 August 1997 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
JMJa Metz
Ja Metz
PKP M Kris-Etherton
P M Kris-Etherton
CMC D Morris
C D Morris
VMVa Mustad
Va Mustad
JSJ S Stern
J S Stern
DMDA McCarron
DA McCarron
Noncompliance with therapeutic diets remains a major obstacle to achieving improvements in cardiovascular disease (CVD) morbidity and mortality. This study compared dietary compliance and CVD risk factor response to two dietary interventions designed to treat hypertension, dyslipidemia, and diabetes mellitus. In a multicenter trial, 560 adults were randomly assigned to either a self-selected, mixed-food plan (n = 277), or a nutrient-fortified prepared meal plan (n = 283); each was designed to provide 15-20% of energy from fat, 55-60% from carbohydrate, and 15-20% from protein. Nutrient intake was estimated from 3-d food records collected biweekly throughout the 10-wk intervention. Compliance was determined by evaluating the participants' ability to meet specific criteria for energy intake [+/-420 kJ (100 kcal) from the midpoint of the prescribed energy range], fat intake (< 20%, < 25%, or < 30% of energy from total fat), and the National Cholesterol Education Program/American Heart Association Step 1 and 2 diet recommendations. Compliance with energy, fat, and Step 1 and 2 criteria was better in participants who followed the prepared meal plan than in those who followed the self-selected diet (P < 0.0001). Compliant participants in both groups achieved greater reductions in body weight, systolic and diastolic blood pressure, and total and low-density-lipoprotein cholesterol than noncompliant participants (P < 0.05). In general, better endpoint responses were observed with lower fat intakes regardless of group assignment. The prepared meal plan is a simple and effective strategy for meeting the many nutrient recommendations for CVD risk reduction and improving dietary compliance and CVD endpoints.

1 January 1988 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
JMJ. A. Metz
J. A. Metz
NKN. Karanja
N. Karanja
JTJ. Torok
J. Torok
DMD. A. McCarron
D. A. McCarron
Studies have indicated that spontaneously hypertensive rats (SHRs) consuming diets high in calcium (Ca2+) and sodium (Na+) weigh less compared to SHRs consuming diets lower in Ca2+ and Na+ while consuming similar amounts of food. Based on calcium’s known effects on lipid metabolism, it was important to determine if manipulations of dietary Ca2+ and Na+ would modify total body fat in the SHR. Fifteen SHRs and 17 Wistar Kyoto rats (WKY) were randomized at 4 weeks of age to three diets varying in Ca2+ and Na+: 2% Ca2+/1.0% Na+, 1% Ca2+/0.45% Na+, and 0.1% Ca2+/0.25% Na+. At 15 weeks of age, blood pressure, body weight, and body composition were determined. Significant differences in body weight, blood pressure, and total body fat were observed between diet groups in both strains. Dietary Ca2+ and Na+ induced favorable changes in total body fat content in both the SHR and WKY. Am J Hypertens 1:58-60, 1988

1 January 1999 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
JMJill A. Metz
Jill A. Metz
CMCynthia D. Morris
Cynthia D. Morris
LRLeslie A. Roberts
Leslie A. Roberts
MMMichael R. McClung
Michael R. McClung
DMDavid A. McCarron
David A. McCarron
Based on the premise that elevated blood pressure and low bone mass have both been associated with poor Ca nutriture and disturbances in Ca metabolism, a cross-sectional study was employed to determine if blood pressure and dietary Ca intake were significantly related to bone mass. Forty-seven men between 24–77 years of age with blood pressure values ranging from normal to mildly elevated comprised the study group. Blood pressure was measured with a random-zero sphygmomanometer. Bone mineral content (BMC) and density (BMD) of the hip, spine and total body were measured with dual-photon absorptiometry. Dietary intake and physical activity were also assessed. Multiple linear regression analysis was used for statistical analysis. After adjusting for known confounding variables (age, BMI, Ca intake, and others) diastolic blood pressure was negatively related to BMC (P ≤ 0·05) and BMD (P ≤ 0·01) of the total body, trochanteric region (P < 0·01) and Ward's triangle (P < 0·05), and to BMC of the femoral neck (P < 0·05) and lumbar spine, although the latter was just shy of statistical significance (P = 0·058). Systolic blood pressure was negatively related to trochanteric BMD (P = 0·04) and BMC (P = 0·06). Ca intake was positively related to total body BMD (P = 0·005), and BMC of the lumbar spine (P = 0·05). In this population of men, Ca intake was a positive predictor, and blood pressure was a negative predictor of regional measures of bone mass. These findings support the concept that independent of age, BMI and Ca intake, elevated blood pressure varies indirectly with bone mass and density, known predictors of osteoporotic fractures. Future studies are needed to determine whether elevated blood pressure is causally related to the development of low bone mass, and what role dietary Ca plays in that pathway.

27 January 1997
Verified
Journal Article
Closed access
DMD A McCarron
D A McCarron
SOS Oparil
S Oparil
ACA Chait
A Chait
RHR B Haynes
R B Haynes
PKP Kris-Etherton
P Kris-Etherton
FPF X Pi-Sunyer
F X Pi-Sunyer

1 October 1986
Verified
Journal Article
Closed access
DHD C Hatton
D C Hatton
PHP S Huie
P S Huie
MMM S Muntzel
M S Muntzel
JMJ A Metz
J A Metz
NKN Karanja
N Karanja
DMD A McCarron
D A McCarron